Systematic review of mTOR inhibitor treatment, biomarkers and prophylaxis for tuberous sclerosis complex-associated seizures

Clin Med (Lond). 2022 Jul;22(Suppl 4):48-49. doi: 10.7861/clinmed.22-4-s48.
No abstract available

Publication types

  • Systematic Review

MeSH terms

  • Biomarkers
  • Humans
  • MTOR Inhibitors
  • Seizures / drug therapy
  • Seizures / etiology
  • Seizures / prevention & control
  • TOR Serine-Threonine Kinases / therapeutic use
  • Tuberous Sclerosis* / complications
  • Tuberous Sclerosis* / drug therapy

Substances

  • Biomarkers
  • MTOR Inhibitors
  • MTOR protein, human
  • TOR Serine-Threonine Kinases